Keyphrases
CD103+ Dendritic Cells
100%
Tumor Immunity
100%
CXCR4 Antagonist
100%
Virotherapy
100%
CD103
75%
Tumor Antigen
75%
Dendritic Cells
50%
Overall Survival
50%
C-X-C Chemokine Receptor Type 4 (CXCR4)
50%
Peptide Vaccine
50%
Tumor
25%
Tumor Growth
25%
Infiltration
25%
Cancer Cells
25%
In Situ
25%
Phagocytic Clearance
25%
Cytotoxic T Cells
25%
Cell Response
25%
Adaptive Immunity
25%
Tumor Model
25%
Anti-tumor Response
25%
Tumor Microenvironment
25%
Polyinosinic-polycytidylic Acid
25%
FMS-like Tyrosine Kinase 3 (FLT3)
25%
Vaccine Response
25%
Viral Antigens
25%
Cellular Materials
25%
Wilms Tumor
25%
In Situ Vaccine
25%
Antigenic Peptide
25%
Oncolytic Vaccinia Virus
25%
Immunosuppressive Network
25%
Locoregional Drug Delivery
25%
Booster Immunization
25%
Armed Virus
25%
Syngeneic Mice
25%
Tumor Load
25%
Metastatic Ovarian Tumor
25%
Immunology and Microbiology
Dendritic Cell
100%
CXCR4
100%
Virotherapy
100%
Tumor Antigen
50%
Overall Survival
33%
Peptides
33%
Adjuvant
16%
Polyinosinic:polycytidylic Acid
16%
Cytokine
16%
Vaccinia Virus
16%
Cytotoxic T Cell
16%
Adaptive Immune System
16%
Syngenic
16%
Immunosuppressive Drug
16%
Cancer Cell
16%
Tumor Vaccine
16%
Virus
16%
Tyrosine
16%